BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• GeoVax to Present at the Third International Conference on Vaccines Research and Development

  Dr. Guirakhoo will discuss GeoVax’s vaccine platform which utilizes its recombinant Modified Vaccinia Ankara (MVA) vector to express foreign antigens on virus-like particles (VLPs) in the person being vaccinated.

  November 13, 2017

   · 

  4 min read
• BriaCell Announces Advancement of its Small Molecule Program and Patent Allowance

  The company disclosed the allowance by the USPTO and also the EPO of two patent applications related to protein kinase C delta (PKCδ) inhibitor technology,

  November 13, 2017

   · 

  6 min read
• Drug Development

  International Stem Cell Corporation Announces Positive Interim Clinical Results for Parkinson’s Disease Clinical Trial

  All patients in the first cohort are currently meeting the primary endpoint, which is safety.

  November 13, 2017

   · 

  7 min read
• Business

  SteadyMed Reports Third Quarter 2017 Financial Results and Provides Corporate Update

  Total operating expenses for the third quarter of 2017 were $5.4 million, compared to $8.0 million for the third quarter of 2016.

  November 13, 2017

   · 

  8 min read
• Business

  Palatin Technologies Reports First Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on November 13, 2017

  Palatin reported net income of $10.6M, or $0.05 per basic and diluted share, for the quarter ended September 30, 2017.

  November 13, 2017

   · 

  15 min read
• Business

  ProMIS Neurosciences Announces Third Quarter 2017 Results

  ProMis Neurosciences today announced its operational and financial results for the three and nine months ended September 30, 2017.

  November 13, 2017

   · 

  7 min read
• Valeant Announces Launch of Private Offering of Add-on Secured Notes

  Valeant announced today that it has launched an offering of $750,000,000 aggregate principal amount of 5.500% senior secured notes due 2025.

  November 13, 2017

   · 

  3 min read
• Bio NC

  vTv to Host Key Opinion Leader Event to Discuss the Current State of Clinical Development in Alzheimer’s Disease

  vTv announced that the Company will host a key opinion leader (KOL) presentation and webcast focused on the current state of clinical development in Alzheimer’s disease in New York City on Thursday, November 16, 2017 from 8:00 am to 10:00 am ET.

  November 13, 2017

   · 

  5 min read
• Policy

  CEL-SCI Announces Update on Arbitration Against Former Clinical Research Organization

  The last witness in the arbitration hearing testified on Wednesday, November 8, 2017, and no further witnesses or testimony are expected.

  November 13, 2017

   · 

  3 min read
• Genetown

  Thermo Scientific TruNarc Analyzer Now Detects Carfentanil

  Law enforcement agents, narcotics officers and customs personnel can now quickly and safely identify the synthetic opioid carfentanil and dozens of additional emerging drugs with the newest library update for the Thermo Fisher Scientific TruNarc handheld narcotics analyzer.

  November 13, 2017

   · 

  3 min read